Medicare Will Cover New Class of Alzheimer Drugs if Fully Approved by FDA, With Limits
Drug makers will also have to gather and keep data in a registry showing how the drugs are working in the real world
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.